Humidity-induced changes of the aerodynamic properties of dry powder aerosol formulations containing different carriers
- PMID: 17064863
- DOI: 10.1016/j.ijpharm.2006.09.048
Humidity-induced changes of the aerodynamic properties of dry powder aerosol formulations containing different carriers
Abstract
This paper presents the findings of two related studies. The aim of the first was to study any changes in the aerodynamic properties of salbutamol base powder formulations when different sugars were used as the carriers, after storage at an elevated humidity (75% RH), and whether any such changes (if any) were related to the physical properties of the carriers. The aim of the second was to investigate whether "ageing", i.e. storage of the carrier, drug and blends under desiccation for more than 2 years, affected the aerodynamic properties of salbutamol sulphate powder formulations. Different formulations were prepared, each containing 1.5% (w/w) micronised salbutamol base or sulphate blended with the sieved fraction (63-90 microm) of one of the following sugars: alpha lactose monohydrate, sorbitol, maltose and dextrose. The salbutamol base blends were then stored unprotected at 75% RH (ambient temperature) and salbutamol fine particle fractions (FPFs) were measured by laser diffraction (LD) (% < 5.2 microm) and a multistage liquid impinger (MSLI) (% < 5.3 microm), following aerosolisation at 100 l min(-1) from a model glass inhaler, after storage of each formulation at the elevated conditions for 0, 1 and 6 days. Particle morphology and equilibrium moisture content (EMC) of each formulation prior to and after storage were also evaluated. However, the salbutamol sulphate blends containing either "fresh" or "aged" components were only characterized using LD at 60 l min(-1). Prior to exposure to 75% RH, the lactose blend was found to give the highest FPF of salbutamol (30% by LD and 37% by MSLI), followed by the sorbitol blend (17% by LD and 29% by MSLI), then by the dextrose blend (15% by LD and 25% by MSLI) and finally by the maltose blend (13% by LD and 13% by MSLI). Exposure to 75% RH for 6 days resulted in a small reduction of salbutamol FPF from the lactose blend but drastic diminution of salbutamol FPFs from other blends. After exposure to the high RH, the lactose blend adsorbed ca. 0.4% whilst each of the other sugars took up larger quantities of water (15-40%) and underwent a marked change in the surface texture of the particles. "Ageing" of the carriers and/or formulations did not seem to alter the aerodynamic properties of the drug. "Ageing" of micronised salbutamol sulphate prior to blending, however, was found to improve the FPF of drug. LD was capable of detecting subtle differences between the various formulations and generated FPF results that correlated with those measured by MSLI.
Similar articles
-
Development of a laser diffraction method for the determination of the particle size of aerosolised powder formulations.Int J Pharm. 2006 Dec 1;326(1-2):39-49. doi: 10.1016/j.ijpharm.2006.07.021. Epub 2006 Jul 16. Int J Pharm. 2006. PMID: 16942848
-
Influence of realistic inspiratory flow profiles on fine particle fractions of dry powder aerosol formulations.Pharm Res. 2007 Feb;24(2):361-9. doi: 10.1007/s11095-006-9156-5. Epub 2006 Dec 20. Pharm Res. 2007. PMID: 17177114 Clinical Trial.
-
Effect of milling and sieving on functionality of dry powder inhalation products.Int J Pharm. 2006 Feb 17;309(1-2):51-9. doi: 10.1016/j.ijpharm.2005.10.043. Epub 2005 Dec 27. Int J Pharm. 2006. PMID: 16377105
-
Lactose characteristics and the generation of the aerosol.Adv Drug Deliv Rev. 2012 Mar 15;64(3):233-56. doi: 10.1016/j.addr.2011.05.003. Epub 2011 May 13. Adv Drug Deliv Rev. 2012. PMID: 21616107 Review.
-
Drug-lactose binding aspects in adhesive mixtures: controlling performance in dry powder inhaler formulations by altering lactose carrier surfaces.Adv Drug Deliv Rev. 2012 Mar 15;64(3):275-84. doi: 10.1016/j.addr.2011.07.002. Epub 2011 Jul 18. Adv Drug Deliv Rev. 2012. PMID: 21782866 Review.
Cited by
-
Lactose composite carriers for respiratory delivery.Pharm Res. 2009 Apr;26(4):802-10. doi: 10.1007/s11095-008-9779-9. Epub 2008 Nov 18. Pharm Res. 2009. PMID: 19015956
-
Comparison of toad skins Bufo bufo gargarizans Cantor from different regions for their active constituents content and cytotoxic activity on lung carcinoma cell lines.Pharmacogn Mag. 2014 Jul;10(39):207-12. doi: 10.4103/0973-1296.137358. Pharmacogn Mag. 2014. PMID: 25210305 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous